The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012–2023)
There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.
Authors
- Inés Aguinaga-Ontoso (ORCID: https://orcid.org/0000-0002-2882-930X)
- Laura Guillén-Aguinaga (ORCID: https://orcid.org/0000-0001-7594-6755)
- Luc Onambele (ORCID: https://orcid.org/0000-0003-1792-4990)
- Francisco Guillén‐Grima (ORCID: https://orcid.org/0000-0001-9749-8076)
- Esperanza Rayón-Valpuesta (ORCID: https://orcid.org/0000-0003-0335-2362)
- Rosa Alas-Brun (ORCID: https://orcid.org/0000-0003-3450-9342)
- Sara Guillén-Aguinaga (ORCID: https://orcid.org/0000-0003-4748-9520)
- Enrique Aguinaga-Ontoso (ORCID: https://orcid.org/0000-0002-7994-3559)
- Miriam Guillen-Aguinaga
Institutions
- Universidad Complutense de Madrid (ES)
- NEOMA Business School (FR)
- Instituto de Salud Carlos III (ES)
- Navarre Institute of Health Research (ES)
- Clinica Universidad de Navarra (ES)
- Catholic University of Central Africa (CM)
- Hospital Universitario Virgen de la Arrixaca (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- Universidad de Murcia (ES)
- Universidad de Navarra (ES)
Publication Details
- Journal
- Vaccines
- Published
- 2024-12-24
- DOI
- https://doi.org/10.3390/vaccines13010006
- Citations
- 5
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 2.64
Funders
- UNICEF